Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease

References

• Abebe A, Demissie D, Goudsmit J, Brouwer M, Kuiken C L, Pollakis G, Schuitemaker H, Fontanet A L, Rinke de Wit T F. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS 1999; 13: 1305–1311
   PubMed Web of Science ®Google Scholar
• Alexander C S, Montessori V, Wynhoven B, Dong W, Chan K, O'Shaughnessy M V, Mo T, Piaseczny M, Montaner J S, Harrigan P R. Prevalence and response to antiretroviral therapy of non-B subtypes of HIV in antiretroviral-naive individuals in British Columbia. Antivir Ther 2002; 7: 31–35
   PubMed Web of Science ®Google Scholar
• Bangham C R. Retrovirus infections of the nervous system. Curr Opin Neurol Neurosurg 1993; 6: 176–181
   PubMedGoogle Scholar
• Behnisch T, Francesconi W, Sanna P P. HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region. Brain Res 2004; 1012: 187–189
   PubMed Web of Science ®Google Scholar
• Bjorndal A, Deng H, Jansson M, Fiore J R, Colognesi C, Karlsson A, Albert J, Scarlatti G, Littman D R, Fenyo E M. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997; 71: 7478–7487
   PubMed Web of Science ®Google Scholar
• Bocket L, Cheret A, Deuffic-Burban S, Choisy P, Gerard Y, de la Tribonniere X, Viget N, Ajana F, Goffard A, Barin F, Mouton Y, Yazdanpanah Y. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness. Antivir Ther 2005; 10: 247–254
   PubMed Web of Science ®Google Scholar
• Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, Tsay J, Ip J, Farthing C, Limoli K, Parkin N, Markowitz M. HIV-1 drug resistance in newly infected individuals. JAMA 1999; 282: 1135–1141
   PubMed Web of Science ®Google Scholar
• Brennan C A, Yamaguchi J, Vallari A S, Hickman R K, Devare S G. Genetic variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma. AIDS Res Hum Retroviruses 1997; 13: 401–404
   PubMed Web of Science ®Google Scholar
• Brodine S K, Shaffer R A, Starkey M J, Tasker S A, Gilcrest J L, Louder M K, Barile A, Van Cott T C, Vahey M T, McCutchan F E, Birx D L, Richman D D, Mascola J R. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med 1999; 131: 502–506
   PubMed Web of Science ®Google Scholar
• Cao Y, Qin L, Zhang L, Safrit J, Ho D D. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995; 332: 201–208
   PubMed Web of Science ®Google Scholar
• Clavel F, Guyader M, Guetard D, Salle M, Montagnier L, Alizon M. Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature 1986; 324: 691–695
   PubMed Web of Science ®Google Scholar
• Clements J E, Babas T, Mankowski J L, Suryanarayana K, Piatak M, Jr, Tarwater P M, Lifson J D, Zink M C. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 2002; 186: 905–913
   PubMed Web of Science ®Google Scholar
• Costello C, Nelson K E, Suriyanon V, Sennun S, Tovanabutra S, Heilig C M, Shiboski S, Jamieson D J, Robison V, Rungruenthanakit K, Duerr A. HIV-1 subtype E progression among northern Thai couples: traditional and non-traditional predictors of survival. Int J Epidemiol 2005; 34: 577–584
   PubMed Web of Science ®Google Scholar
• Damond F, Apetrei C, Robertson D L, Souquiere S, Lepretre A, Matheron S, Plantier J C, Brun-Vezinet F, Simon F. Variability of human immunodeficiency virus type 2 (HIV-2) infecting patients living in france. Virology 2001; 280: 19–30
   PubMed Web of Science ®Google Scholar
• Davis L E, Hjelle B L, Miller V E, Palmer D L, Llewellyn A L, Merlin T L, Young S A, Mills R G, Wachsman W, Wiley C A. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992; 42: 1736–1739
   PubMed Web of Science ®Google Scholar
• De Jong J J, De Ronde A, Keulen W, Tersmette M, Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol 1992; 66: 6777–6780
   PubMed Web of Science ®Google Scholar
• De Wit S, Boulme R, Poll B, Schmit J C, Clumeck N. Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients. AIDS 2004; 18: 2330–2331
   PubMed Web of Science ®Google Scholar
• De Wolf F, Hogervorst E, Goudsmit J, Fenyo E M, Rubsamen-Waigmann H, Holmes H, Galvao-Castro B, Karita E, Wasi C, Sempala S D, et al. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses 1994; 10: 1387–1400
   PubMed Web of Science ®Google Scholar
• Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, Simon F, Saragosti S, Brun-Vezinet F. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol 1997; 71: 8893–8898
   PubMed Web of Science ®Google Scholar
• Descamps D, Collin G, Loussert-Ajaka I, Saragosti S, Simon F, Brun-Vezinet F. HIV-1 group O sensitivity to antiretroviral drugs. AIDS 1995; 9: 977–978
   Web of Science ®Google Scholar
• Donnelly C, Leisenring W, Kanki P, Awerbuch T, Sandberg S. Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal. Bull Math Biol 1993; 55: 731–743
   PubMed Web of Science ®Google Scholar
• Dreyer E B, Kaiser P K, Offermann J T, Lipton S A. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990; 248: 364–367
   PubMed Web of Science ®Google Scholar
• Englund G, Theodore T S, Freed E O, Engelman A, Martin M A. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J Virol 1995; 69: 3216–3219
   PubMed Web of Science ®Google Scholar
• Epstein L G, Gendelman H E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 1993; 33: 429–436
   PubMed Web of Science ®Google Scholar
• Eshleman S H, Becker-Pergola G, Deseyve M, Guay L A, Mracna M, Fleming T, Cunningham S, Musoke P, Mmiro F, Jackson J B. Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 study). J Infect Dis 2001; 184: 914–917
   PubMed Web of Science ®Google Scholar
• Gao F, Bailes E, Robertson D L, Chen Y, Rodenburg C M, Michael S F, Cummins L B, Arthur L O, Peeters M, Shaw G M, Sharp P M, Hahn B H. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999; 397: 436–441
   PubMed Web of Science ®Google Scholar
• Gao F, Morrison S G, Robertson D L, Thornton C L, Craig S, Karlsson G, Sodroski J, Morgado M, Galvao-Castro B, von Briesen H, Beddows S, Weber J, Sharp P M, Shaw G M, Hahn B H. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization. J Virol 1996; 70: 1651–1667
   PubMed Web of Science ®Google Scholar
• Gao F, Robertson D L, Carruthers C D, Morrison S G, Jian B, Chen Y, Barre-Sinoussi F, Girard M, Srinivasan A, Abimiku A G, Shaw G M, Sharp P M, Hahn B H. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 1998; 72: 5680–5698
   PubMed Web of Science ®Google Scholar
• Gao F, Vidal N, Li Y, Trask S A, Chen Y, Kostrikis L G, Ho D D, Kim J, Oh M D, Choe K, Salminen M, Robertson D L, Shaw G M, Hahn B H, Peeters M. Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. AIDS Res Hum Retroviruses 2001; 17: 675–688
   PubMed Web of Science ®Google Scholar
• Gendelman H E, Genis P, Jett M, Zhai Q H, Nottet H S. An experimental model system for HIV-1-induced brain injury. Adv Neuroimmunol 1994; 4: 189–193
   PubMedGoogle Scholar
• Geretti A M. HIV-1 subtypes: epidemiology and significance for HIV management. Curr Opin Infect Dis 2006; 19: 1–7
   PubMed Web of Science ®Google Scholar
• Glass J D, Fedor H, Wesselingh S L, McArthur J C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995; 38: 755–762
   PubMed Web of Science ®Google Scholar
• Grossman Z, Istomin V, Averbuch D, Lorber M, Risenberg K, Levi I, Chowers M, Burke M, Bar Yaacov N, Schapiro J M. Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C. AIDS 2004a; 18: 909–915
   PubMed Web of Science ®Google Scholar
• Grossman Z, Paxinos E E, Averbuch D, Maayan S, Parkin N T, Engelhard D, Lorber M, Istomin V, Shaked Y, Mendelson E, Ram D, Petropoulos C J, Schapiro J M. Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. Antimicrob Agents Chemother 2004b; 48: 2159–2165
   PubMed Web of Science ®Google Scholar
• Hahn B H, Shaw G M, De Cock K M, Sharp P M. AIDS as a zoonosis: scientific and public health implications. Science 2000; 287: 607–614
   PubMed Web of Science ®Google Scholar
• Harrington P R, Haas D W, Ritola K, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells. J Virol 2005; 79: 7959–7966
   PubMed Web of Science ®Google Scholar
• Hemelaar J, Gouws E, Ghys P D, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006; 20: W13–W23
   PubMed Web of Science ®Google Scholar
• HIV Sequence Database. Los Alamos National Laboratory. 2006
   Google Scholar
• Hsu L Y, Subramaniam R, Bacheler L, Paton N I. Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment-naive and -experienced patients in Singapore. J Acquir Immune Defic Syndr 2005; 38: 5–13
   PubMed Web of Science ®Google Scholar
• Hu D J, Buve A, Baggs J, van der Groen G, Dondero T J. What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. AIDS 1999; 13: 873–881
   PubMed Web of Science ®Google Scholar
• Hwang S S, Boyle T J, Lyerly H K, Cullen B R. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991; 253: 71–74
   PubMed Web of Science ®Google Scholar
• Ida S, Gatanaga H, Shioda T, Nagai Y, Kobayashi N, Shimada K, Kimura S, Iwamoto A, Oka S. HIV type 1 V3 variation dynamics in vivo: long-term persistence of non-syncytium-inducing genotypes and transient presence of syncytium-inducing genotypes during the course of progressive AIDS. AIDS Res Hum Retroviruses 1997; 13: 1597–1609
   PubMed Web of Science ®Google Scholar
• Jaffe H W, Schochetman G. Group O human immunodeficiency virus-1 infections. Infect Dis Clin North Am 1998; 12: 39–46
   PubMed Web of Science ®Google Scholar
• Johnson R T, Glass J D, McArthur J C, Chesebro B W. Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann Neurol 1996; 39: 392–395
   PubMed Web of Science ®Google Scholar
• Johnston J B, Jiang Y, van Marle G, Mayne M B, Ni W, Holden J, McArthur J C, Power C. Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity. J Virol 2000; 74: 7211–7220
   PubMed Web of Science ®Google Scholar
• Jones M, Olafson K, BDel igio M R, Peeling J, Nath A. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J Neuropathol Exp Neurol 1998; 57: 563–570
   PubMed Web of Science ®Google Scholar
• Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, Nakiyingi J, Rutebemberwa A, Morgan D, Weber J, Gilks C, Whitworth J. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002; 185: 1244–1250
   PubMed Web of Science ®Google Scholar
• Kaleebu P, Nankya I L, Yirrell D L, Shafer L A, Kyosiimire-Lugemwa J, Lule D B, Morgan D, Beddows S, Weber J, Whitworth J A. Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr May 1, 2007; 45(1)28–33, 2007
   PubMed Web of Science ®Google Scholar
• Kandathil A J, Ramalingam S, Kannangai R, David S, Sridharan G. Molecular epidemiology of HIV. Indian J Med Res 2005; 121: 333–344
   PubMed Web of Science ®Google Scholar
• Kanki P J, Hamel D J, Sankale J L, Hsieh C, Thior I, Barin F, Woodcock S A, Gueye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, Essex M E, SMB. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179: 68–73
   PubMed Web of Science ®Google Scholar
• Kanki P J, Travers K USMB, Hsieh C C, Marlink R G, Gueye N A, Siby T, Thior I, Hernandez-Avila M, Sankale J L, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343: 943–946
   PubMed Web of Science ®Google Scholar
• Kantor R, Katzenstein D A, Efron B, Carvalho A P, Wynhoven B, Cane P, Clarke J, Sirivichayakul S, Soares M A, Snoeck J, Pillay C, Rudich H, Rodrigues R, Holguin A, Ariyoshi K, Bouzas M B, Cahn P, Sugiura W, Soriano V, Brigido L F, Grossman Z, Morris L, Vandamme A M, Tanuri A, Phanuphak P, Weber J N, Pillay D, Harrigan P R, Camacho R, Schapiro J M, Shafer R W. Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med 2005; 2: e112
   PubMed Web of Science ®Google Scholar
• Kaul M, Lipton S A. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 1999; 96: 8212–8216
   PubMed Web of Science ®Google Scholar
• Keet I P, Krijnen P, Koot M, Lange J M, Miedema F, Goudsmit J, Coutinho R A. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993; 7: 51–57
   PubMed Web of Science ®Google Scholar
• Kijak G H, McCutchan F E. HIV diversity, molecular epidemiology, and the role of recombination. Curr Infect Dis Rep 2005; 7: 480–488
   PubMedGoogle Scholar
• Kilmarx P H, Limpakarnjanarat K, Kaewkungwal J, Srismith R, Saisorn S, Uthaivoravit W, Young N L, Mastro T D. Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand. J Infect Dis 2000; 181: 1598–1606
   PubMed Web of Science ®Google Scholar
• Kong L Y, Wilson B C, McMillian M K, Bing G, Hudson P M, Hong J S. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol 1996; 172: 77–83
   PubMed Web of Science ®Google Scholar
• Koot M, Keet I P, Vos A H, de Goede R E, Roos M T, Coutinho R A, Miedema F, Schellekens P T, Tersmette M. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993; 118: 681–688
   PubMed Web of Science ®Google Scholar
• Kozak S L, Platt E J, Madani N, Ferro F E, Jr., Peden K, Kabat D. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol 1997; 71: 873–882
   PubMed Web of Science ®Google Scholar
• Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell J E, Brack-Werner R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 2005; 111: 194–213
   PubMed Web of Science ®Google Scholar
• Kure K, Lyman W D, Weidenheim K M, Dickson D W. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol 1990; 136: 1085–1092
   PubMed Web of Science ®Google Scholar
• Laeyendecker O, Li X, Arroyo M, McCutchan F, et al. The effect of HIV subtype on rapid disease progression in Rakai, Uganda. Proceedings, 13th Conference on Retroviruses and Opportunistic Infections, Denver, CO, 2006
   Google Scholar
• Lannuzel A, Lledo P M, Lamghitnia H O, Vincent J D, Tardieu M. HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2 +]i increase, alter [Ca2 +]i homeostasis and induce neurotoxicity in human embryonic neurons. Eur J Neurosci 1995; 7: 2285–2293
   PubMed Web of Science ®Google Scholar
• Lazarini F, Seilhean D, Rosenblum O, Suarez S, Conquy L, Uchihara T, Sazdovitch V, Mokhtari K, Maisonobe T, Boussin F, Katlama C, Bricaire F, Duyckaerts C, Hauw J J. Human immunodeficiency virus type 1 DNA and RNA load in brains of demented and nondemented patients with acquired immunodeficiency syndrome. J NeuroVirol 1997; 3: 299–303
   PubMed Web of Science ®Google Scholar
• Levi G, Patrizio M, Bernardo A, Petrucci T C, Agresti C. Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions. Proc Natl Acad Sci U S A. 1993; 90: 1541–1545
   PubMed Web of Science ®Google Scholar
• Levy J A. Viral and cellular factors influencing HIV tropism. Adv Exp Med Biol 1991; 300: 1–15
   PubMedGoogle Scholar
• Liesch G R, DeStefano J J. Analysis of mutations made during active synthesis or extension of mismatched substrates further define the mechanism of HIV-RT mutagenesis. Biochemistry 2003; 42: 5925–5936
   PubMed Web of Science ®Google Scholar
• Little S J, Holte S, Routy J P, Daar E S, Markowitz M, Collier A C, Koup R A, Mellors J W, Connick E, Conway B, Kilby M, Wang L, Whitcomb J M, Hellmann N S, Richman D D. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002; 347: 385–394
   PubMed Web of Science ®Google Scholar
• Littman D R. Chemokine receptors: keys to AIDS pathogenesis?. Cell 1998; 93: 677–680
   PubMed Web of Science ®Google Scholar
• Liu P, Hudson L C, Tompkins M B, Vahlenkamp T W, Colby B, Rundle C, Meeker R B. Cerebrospinal fluid is an efficient route for establishing brain infection with feline immunodeficiency virus and transfering infectious virus to the periphery. J NeuroVirol 2006; 12: 294–306
   PubMed Web of Science ®Google Scholar
• Loemba H, Brenner B, Parniak M A, Ma'ayan S, Spira B, Moisi D, Oliveira M, Detorio M, Wainberg M A. Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. Antimicrob Agents Chemother 2002; 46: 2087–2094
   PubMed Web of Science ®Google Scholar
• Lynch W P, Czub S, McAtee F J, Hayes S F, Portis J L. Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron 1991; 7: 365–379
   PubMed Web of Science ®Google Scholar
• Maniar J K, Damond F, Kamath R R, Mandalia S, Surjushe A. Antiretroviral drug-resistant HIV-2 infection—a new therapeutic dilemma. Int J STD AIDS 2006; 17: 781–782
   PubMed Web of Science ®Google Scholar
• Mankowski J L, Flaherty M T, Spelman J P, Hauer D A, Didier P J, Amedee A M, Murphey-Corb M, Kirstein L M, Munoz A, Clements J E, Zink M C. Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol 1997; 71: 6055–6060
   PubMed Web of Science ®Google Scholar
• Maragos W F, Tillman P, Jones M, Bruce-Keller A J, Roth S, Bell J E, Nath A. Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat. Neuroscience 2003; 117: 43–53
   PubMed Web of Science ®Google Scholar
• Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh C C, Dia M C, Gueye E H, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265: 1587–1590
   PubMed Web of Science ®Google Scholar
• Masliah E, Ge N, Achim C L, Hansen L A, Wiley C A. Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 1992; 51: 585–593
   PubMed Web of Science ®Google Scholar
• Masliah E, Heaton R K, Marcotte T D, Ellis R J, Wiley C A, Mallory M, Achim C L, McCutchan J A, Nelson J A, Atkinson J H, Grant I. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997; 42: 963–972
   PubMed Web of Science ®Google Scholar
• Mattson M P, Haughey N J, Nath A. Cell death in HIV dementia. Cell Death Differ 2005; 12: 893–904, (Suppl 1)
   PubMed Web of Science ®Google Scholar
• McArthur J C, McDermott M P, McClernon D, St Hillaire C, Conant K, Marder K, Schifitto G, Selnes O A, Sacktor N, Stern Y, Albert S M, Kieburtz K, de Marcaida J A, Cohen B, Epstein L G. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol 2004; 61: 1687–1696
   PubMedGoogle Scholar
• McCutchan F E. Global epidemiology of HIV. J Med Virol 2006; 78: S7–S12, (Suppl 1)
   PubMed Web of Science ®Google Scholar
• Mehendale S M, Bollinger R C, Kulkarni S S, Stallings R Y, Brookmeyer R S, Kulkarni S V, Divekar A D, Gangakhedkar R R, Joshi S N, Risbud A R, Thakar M A, Mahajan B A, Kale V A, Ghate M V, Gadkari D A, Quinn T C, Paranjape R S. Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India. AIDS Res Hum Retroviruses 2002; 18: 1175–1179
   PubMed Web of Science ®Google Scholar
• Mendez I, Swanson M, Coombs K. Introduction to Virus Structure, Classification, Replication, and Hosts. Clinical neurovirology, A Nath, J Berger. Marcel Dekker, New York 2003; 634
   Google Scholar
• Merrill J E, Koyanagi Y, Zack J, Thomas L, Martin F, Chen I S. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 1992; 66: 2217–2225
   PubMed Web of Science ®Google Scholar
• Mollace V, Colasanti M, Persichini T, Bagetta G, Lauro G M, Nistico G. HIV gp120 glycoprotein stimulates the inducible isoform of no synthase in human cultured astrocytoma cells. Biochem Biophys Res Commun 1993; 194: 439–445
   PubMed Web of Science ®Google Scholar
• Morris A, Marsden M, Halcrow K, Hughes E S, Brettle R P, Bell J E, Simmonds P. Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations. J Virol 1999; 73: 8720–8731
   PubMed Web of Science ®Google Scholar
• Nath A, Conant K, Chen P, Scott C, Major E O. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 1999; 274: 17098–17102
   PubMed Web of Science ®Google Scholar
• Nielsen C, Pedersen C, Lundgren J D, Gerstoft J. Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 1993; 7: 1035–1040
   PubMed Web of Science ®Google Scholar
• Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier J L, Arenzana-Seisdedos F, Schwartz O, Heard J M, Clark-Lewis I, Legler D F, Loetscher M, Baggiolini M, Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 382: 833–835
   PubMed Web of Science ®Google Scholar
• Ohagen A, Ghosh S, He J, Huang K, Chen Y, Yuan M, Osathanondh R, Gartner S, Shi B, Shaw G, Gabuzda D. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J Virol 1999; 73: 897–906
   PubMed Web of Science ®Google Scholar
• Palmer S, Alaeus A, Albert J, Cox S. Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses 1998; 14: 157–162
   PubMed Web of Science ®Google Scholar
• Patton H K, Zhou Z H, Bubien J K, Benveniste E N, Benos D J. gp120-induced alterations of human astrocyte function: Na(+)/H(+) exchange, K(+) conductance, and glutamate flux. Am J Physiol Cell Physiol 2000; 279: C700–C708
   PubMed Web of Science ®Google Scholar
• Peeters M, Vincent R, Perret J L, Lasky M, Patrel D, Liegeois F, Courgnaud V, Seng R, Matton T, Molinier S, Delaporte E. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 115–121
   PubMedGoogle Scholar
• Philippon V, Vellutini C, Gambarelli D, Harkiss G, Arbuthnott G, Metzger D, Roubin R, Filippi P. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 1994; 205: 519–529
   PubMed Web of Science ®Google Scholar
• Pieniazek D, Ellenberger D, Janini L M, Ramos A C, Nkengasong J, Sassan-Morokro M, Hu D J, Coulibally I M, Ekpini E, Bandea C, Tanuri A, Greenberg A E, Wiktor S Z, Rayfield M A. Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast. AIDS Res Hum Retroviruses 1999; 15: 603–608
   PubMed Web of Science ®Google Scholar
• Pillay D, Walker A S, Gibb D M, de Rossi A, Kaye S, Ait-Khaled M, Munoz-Fernandez M, Babiker A. Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial. J Infect Dis 2002; 186: 617–625
   PubMed Web of Science ®Google Scholar
• Ping L H, Nelson J A, Hoffman I F, Schock J, Lamers S L, Goodman M, Vernazza P, Kazembe P, Maida M, Zimba D, Goodenow M M, Eron J J, Jr, Fiscus S A, Cohen M S, Swanstrom R. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol 1999; 73: 6271–6281
   PubMed Web of Science ®Google Scholar
• Power C, McArthur J C, Johnson R T, Griffin D E, Glass J D, Perryman S, Chesebro B. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 1994; 68: 4643–4649
   PubMed Web of Science ®Google Scholar
• Power C, McArthur J C, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson R T, Chesebro B. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol 1998; 72: 9045–9053
   PubMed Web of Science ®Google Scholar
• Power C, Zhang K, van Marle G. Comparative neurovirulence in lentiviral infections: The roles of viral molecular diversity and select proteases. J NeuroVirol 2004; 10: 113–117, (Suppl 1)
   PubMed Web of Science ®Google Scholar
• Preston B D, Poiesz B J, Loeb L A. Fidelity of HIV-1 reverse transcriptase. Science 1988; 242: 1168–1171
   PubMed Web of Science ®Google Scholar
• Reeves J D, Doms R W. Human immunodeficiency virus type 2. J Gen Virol 2002; 83: 1253–1265
   PubMed Web of Science ®Google Scholar
• Ren J, Bird L E, Chamberlain P P, Stewart-Jones G B, Stuart D I, Stammers D K. Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc Natl Acad Sci U S A 2002; 99: 14410–14415
   PubMed Web of Science ®Google Scholar
• Ritola K, Robertson K, Fiscus S A, Hall C, Swanstrom R. Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol 2005; 79: 10830–10834
   PubMed Web of Science ®Google Scholar
• Roberts J D, Bebenek K, Kunkel T A. The accuracy of reverse transcriptase from HIV-1. Science 1988; 242: 1171–1173
   PubMed Web of Science ®Google Scholar
• Robertson D L, Anderson J P, Bradac J A, Carr J K, Foley B, Funkhouser R K, Gao F, Hahn B H, Kalish M L, Kuiken C, Learn G H, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp P M, Wolinsky S, Korber B. HIV-1 nomenclature proposal. Science 2000; 288: 55–56
   PubMed Web of Science ®Google Scholar
• Rodes B, Toro C, Paxinos E, Poveda E, Martinez-Padial M, Benito J M, Jimenez V, Wrin T, Bassani S, Soriano V. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS 2004; 18: 1109–1116
   PubMed Web of Science ®Google Scholar
• Sevigny J J, Albert S M, McDermott M P, McArthur J C, Sacktor N, Conant K, Schifitto G, Selnes O A, Stern Y, McClernon D R, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein L G, Marder K. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 2004; 63: 2084–2090
   PubMed Web of Science ®Google Scholar
• Sharp P M, Robertson D L, Hahn B H. Cross-species transmission and recombination of ‘AIDS’ viruses. Philos Trans R Soc Lond B Biol Sci 1995; 349: 41–47
   PubMed Web of Science ®Google Scholar
• Simon F, Mauclere P, Roques P, Loussert-Ajaka I, Muller-Trutwin M C, Saragosti S, Georges-Courbot M C, Barre-Sinoussi F, Brun-Vezinet F. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998; 4: 1032–1037
   PubMed Web of Science ®Google Scholar
• Simon V, Ho D D. HIV-1 dynamics in vivo: implications for therapy. Nat Rev Microbiol 2003; 1: 181–190
   PubMed Web of Science ®Google Scholar
• Simon V, Vanderhoeven J, Hurley A, Ramratnam B, Louie M, Dawson K, Parkin N, Boden D, Markowitz M. Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals. AIDS 2002; 16: 1511–1519
   PubMed Web of Science ®Google Scholar
• Smit T K, Brew B J, Tourtellotte W, Morgello S, Gelman B B, Saksena N K. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. J Virol 2004; 78: 10133–10148
   PubMed Web of Science ®Google Scholar
• Soriano V, Gomes P, Heneine W, Holguin A, Doruana M, Antunes R, Mansinho K, Switzer W M, Araujo C, Shanmugam V, Lourenco H, Gonzalez-Lahoz J, Antunes F. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J Med Virol 2000; 61: 111–116
   PubMed Web of Science ®Google Scholar
• Soto-Ramirez L E, Renjifo B, McLane M F, Marlink R, O'Hara C, Sutthent R, Wasi C, Vithayasai P, Vithayasai V, Apichartpiyakul C, Auewarakul P, Pena Cruz V, Chui D S, Osathanondh R, Mayer K, Lee T H, Essex M. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996; 271: 1291–1293
   PubMed Web of Science ®Google Scholar
• Spira S, Wainberg M A, Loemba H, Turner D, Brenner B G. Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemother 2003; 51: 229–240
   PubMed Web of Science ®Google Scholar
• Stevenson M, Haggerty S, Lamonica C A, Meier C M, Welch S K, Wasiak A J. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol 1990; 64: 2421–2425
   PubMed Web of Science ®Google Scholar
• Takahashi K, Wesselingh S L, Griffin D E, McArthur J C, Johnson R T, Glass J D. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996; 39: 705–711
   PubMed Web of Science ®Google Scholar
• Tantillo C, Ding J, Jacobo-Molina A, Nanni R G, Boyer P L, Hughes S H, Pauwels R, Andries K, Janssen P A, Arnold E. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J Mol Biol 1994; 243: 369–387
   PubMed Web of Science ®Google Scholar
• Teo I, Veryard C, Barnes H, An S F, Jones M, Lantos P L, Luthert P, Shaunak S. Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol 1997; 71: 2928–2933
   PubMed Web of Science ®Google Scholar
• Tersmette M, de Goede R E, Al B J, Winkel I N, Gruters R A, Cuypers H T, Huisman H G, Miedema F. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 1988; 62: 2026–2032
   PubMed Web of Science ®Google Scholar
• Thomson M M, Perez-Alvarez L, Najera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002; 2: 461–471
   PubMed Web of Science ®Google Scholar
• Toggas S M, Masliah E, Rockenstein E M, Rall G F, Abraham C R, Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994; 367: 188–193
   PubMed Web of Science ®Google Scholar
• Trillo-Pazos G, Diamanturos A, Rislove L, Menza T, Chao W, Belem P, Sadiq S, Morgello S, Sharer L, Volsky D J. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 2003; 13: 144–154
   PubMed Web of Science ®Google Scholar
• Tscherning C, Alaeus A, Fredriksson R, Bjorndal A, Deng H, Littman D R, Fenyo E M, Albert J. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998; 241: 181–188
   PubMed Web of Science ®Google Scholar
• Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, Fawzi W, Hunter D. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006; 42: 843–852
   PubMed Web of Science ®Google Scholar
• Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, Toure-Kane C, Mboup S, Mulanga-Kabeya C, Saman E, Jourdan J, Reynes J, Delaporte E. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol 2000; 38: 3919–3925
   PubMed Web of Science ®Google Scholar
• Vidal N, Peeters M, Mulanga-Kabeya C, Nzilambi N, Robertson D, Ilunga W, Sema H, Tshimanga K, Bongo B, Delaporte E. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000; 74: 10498–10507
   PubMed Web of Science ®Google Scholar
• Wiskerchen M, Muesing M A. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J Virol 1995; 69: 376–386
   PubMed Web of Science ®Google Scholar
• Yang C, Li M, Mokili J L, Winter J, Lubaki N M, Mwandagalirwa K M, Kasali M J, Losoma A J, Quinn T C, Bollinger R C, Lal R B. Genetic diversification and recombination of HIV type 1 group M in Kinshasa, Democratic Republic of Congo. AIDS Res Hum Retroviruses 2005; 21: 661–666
   PubMed Web of Science ®Google Scholar
• Yang G, Song Q, Charles M, Drosopoulos W C, Arnold E, Prasad V R. Use of chimeric human immunodeficiency virus types 1 and 2 reverse transcriptases for structure-function analysis and for mapping susceptibility to nonnucleoside inhibitors. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11: 326–333
   PubMedGoogle Scholar
• Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate D F, Solomon S, Flanigan T. Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc 2006; 12: 424–430
   PubMed Web of Science ®Google Scholar
• Yerly S, Kaiser L, Race E, Bru J P, Clavel F, Perrin L. Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet 1999; 354: 729–733
   PubMed Web of Science ®Google Scholar
• Yeung M C, Pulliam L, Lau A S. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS 1995; 9: 137–143
   PubMed Web of Science ®Google Scholar
• Zekeng L, Gurtler L, Afane Ze E, Sam-Abbenyi A, Mbouni-Essomba G, Mpoudi-Ngolle E, Monny-Lobe M, Tapka J B, Kaptue L. Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results. AIDS 1994; 8: 1626–1628
   PubMed Web of Science ®Google Scholar
• Zhang K, Hawken M, Rana F, Welte F J, Gartner S, Goldsmith M A, Power C. Human immunodeficiency virus type 1 clade A and D neurotropism: molecular evolution, recombination, and coreceptor use. Virology 2001; 283: 19–30
   PubMed Web of Science ®Google Scholar
• Zhang K, Rana F, Silva C, Ethier J, Wehrly K, Chesebro B, Power C. Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity. J Virol 2003; 77: 6899–6912
   PubMed Web of Science ®Google Scholar
• Zhang L, Huang Y, He T, Cao Y, Ho D D. HIV-1 subtype and second-receptor use. Nature 1996; 383: 768
   PubMed Web of Science ®Google Scholar
• Zhao M L, Kim M O, Morgello S, Lee S C. Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis. J Neuroimmunol 2001; 115: 182–191
   PubMed Web of Science ®Google Scholar
• Zhong P, Peeters M, Janssens W, Fransen K, Heyndrickx L, Vanham G, Willems B, Piot P, van der Groen G. Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses 1995; 11: 239–248
   PubMed Web of Science ®Google Scholar
• Zink M C, Clements J E. A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease. J NeuroVirol 2002; 8: 42–48, (Suppl 2)
   PubMed Web of Science ®Google Scholar